Skip to main content
Premium Trial:

Request an Annual Quote

IP Roundup: J&J, Autogenomics, Panasonic, Tufts, Immucor, Harvard, Iris Biotechnology, and Others

Premium

Title: Fluorescence reader
Patent Number: 8,691,153
Filed: March 22, 2007
Lead Inventor: Tomas Lindstrom, J&J


Title: Concurrent analysis of multiple patient samples using solid phase addressable multiplex test with high signal-to-noise ratio.
Patent Number: 8,691,598
Filed: Dec. 13, 2007
Lead Inventor: Nanibhushan Dattagupta, Autogenomics


Title: Biomolecule substrate, and test and diagnosis methods and apparatuses using the same.
Patent Number: 8,691,560
Filed: Oct. 1, 2010
Lead Inventor: Mitsuaka Oshimi, Panasonic


Title: Self-encoding sensor with microspheres.
Patent Number: 8,691,591
Filed: March 25, 2013
Lead Inventor: David Walt, Tufts College


Title: Method of making a microbead array with attached biomolecules.
Patent Number: 8,691,594
Filed: Oct. 31, 2012
Lead Inventor: Michael Seul, Immucor


Title: Reaction discovery system.
Patent Number: 8,651,729
Filed: Jan. 9, 2008
Lead Inventor: David Liu, Harvard College


Title: Microparticles with enhanced covalent binding capacity and their uses.
Patent Number: 8,691,594
Filed: June 7, 2010
Lead Inventor: Xinwen Wang, Immucor


Title: Artificial intelligence system for genetic analysis.
Patent Number: 8,693,751
Filed: Jan. 12, 2012
Lead Inventor: Glenn Osborn, Iris Biotechnology


Title: Method and apparatus for imaging of features on a substrate.
Patent Number: 8,692,876
Filed: July 8, 2009
Lead Inventor: Auguste Genovesio, Institut Pasteur Korea


Title: Method of identifying virtual representations of nucleotide sequences.
Patent Number: 8,694,263
Filed: May 21, 2004
Lead Inventor: Michael Wigler, Cold Spring Harbor Laboratory

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.